HC Wainwright Research Analysts Cut Earnings Estimates for ASP Isotopes Inc. (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) – Research analysts at HC Wainwright lowered their FY2024 EPS estimates for ASP Isotopes in a report released on Wednesday, April 17th. HC Wainwright analyst H. Ihle now expects that the company will post earnings of ($0.11) per share for the year, down from their previous estimate of $0.07. HC Wainwright has a “Buy” rating and a $5.50 price objective on the stock. The consensus estimate for ASP Isotopes’ current full-year earnings is $0.07 per share.

ASP Isotopes Stock Performance

Shares of ASPI stock opened at $3.09 on Friday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.01. ASP Isotopes has a 52 week low of $0.28 and a 52 week high of $4.97. The firm’s 50-day simple moving average is $3.67 and its two-hundred day simple moving average is $2.39.

Insiders Place Their Bets

In related news, Director Robert John Andrew Ryan acquired 15,596 shares of the stock in a transaction on Monday, January 29th. The shares were acquired at an average price of $2.35 per share, with a total value of $36,650.60. Following the completion of the transaction, the director now owns 537,055 shares in the company, valued at approximately $1,262,079.25. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 26.30% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

Several institutional investors have recently made changes to their positions in ASPI. Millennium Management LLC purchased a new stake in shares of ASP Isotopes during the fourth quarter worth $49,000. Armistice Capital LLC purchased a new stake in shares of ASP Isotopes during the first quarter worth $2,702,000. Renaissance Technologies LLC purchased a new stake in shares of ASP Isotopes during the second quarter worth $272,000. HTLF Bank purchased a new stake in shares of ASP Isotopes during the fourth quarter worth $141,000. Finally, Rathbones Group PLC purchased a new stake in shares of ASP Isotopes during the fourth quarter worth $272,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.